Poslední aktualizace :
03/05/2024
Rakovina drog   Docetaxel  
Injekce
Stabilita roztoků Stabilita směsí Faktory ovlivňující stabilitu Kompatibilita Způsoby aplikace Odkazy Pdf
   Chemický vzorec  

Obchodní název   Obchodní název     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adenex Kolumbie
Asodocel Argentina
Axogen Chile
Bagotaxel Chile
Bendadocel NÏmecko
Brecasta Chile
Celtere Peru
Daxotel Chile, Egypt, Kolumbie, Malajsie
Doce NC NÏmecko
Docefrez Indie, USA
Docekebir Argentina
Docetax Írán, Venezuela
Docetaxin NÏmecko
Docewin Maroko
Dolectran Argentina
Donataxel Argentina, Ekvádor, Peru
Doxel Turecko, Venezuela
Doxetal Argentina
Doxitax Turecko
Oncodocel Kolumbie, Peru
Onkotaxel Kolumbie, Rakousko
Ribodocel NÏmecko
Santax Turecko
Tadocel Turecko
Taxceus Velká Británie
Taxotan NÏmecko
Taxotere äpanÏlsko, Argentina, Austrálie, Belgie, Chile, Chorvatsko, Dánsko, Egypt, Ekvádor, Finsko, Francie, Írán, Island, Itálie, Japonsko, Kanada, Kolumbie, Lucembursko, Malajsie, MaÔarsko, Maroko, Mexiko, NÏmecko, Nizozemsko, Norsko, Nový Zéland, Polsko, Portugalsko, Rakousko, Rumunsko, Saúdská Arábie, Spojené arabské emiráty, Švédsko, Švýcarsko, Thajsko, Tunisko, Turecko, USA, Velká Británie, Venezuela, ÿecko
Texot Argentina
Tolnexa Rumunsko
Zenotere Indie, Peru
Odkazy   Injekce   Odkazy : Docetaxel  
Typ Uveřejnění
140 Noviny Pearson SD, Trissel LA.
Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components.
Am J Hosp Pharm 1993 ; 50: 1405-1409.
250 Noviny Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.
Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials.
Am J Health-Syst Pharm 1997 ; 54: 566-569.
251 Noviny Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423 Noviny Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1660 Noviny Thiesen J, Krämer I.
Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers.
Pharm World Sci 1999 ; 21: 137-141.
1662 Noviny Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1754 Noviny Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1940 Noviny Xu QA, Trissel LA.
Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953 Noviny Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 Noviny Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175 Noviny Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J.
Peut-on conditionner les solutions de docétaxel dans des poches en PVC ?
J Pharm Clin 2006 ; 25, 3: 147-152.
2210 Noviny Walker S.E, Charbonneau F, Law S.
Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags.
Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262 Noviny Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341 Plakát Bourlon S, Sautou-Miranda V, Dalle M.
Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions
Poster ESCP Stockholm May 2005
3130 Laboratoř Docétaxel (Taxotere®) – Résumé des caractéristiques du produits
Sanofi Avantis France 2009
3163 Noviny Acott SR, Hart M.
Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage.
EJHP 2010 ; 16, 5: 26-28.
3195 Noviny MacLeod S, Sewell G.
Physical and chemical stability of docetaxel infusions.
EJHP 2011 ; 17, 2: 39-43.
3215 Noviny Hart MC, Ahmed W.
Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution.
EJOP 2011 ; 5,1: 24-27.
3277 Noviny Yang Z, Cameron S, Paul H.
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration.
Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804 Noviny Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.
Physicochemical stability of cabazitaxel and docetaxel solutions.
EJHP 2014 ;22:150-155.
3937 Noviny Park K.H, Chung D.J.
Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration.
Biomat Res 2015 ; 19, 2

  Mentions Légales